The art of finding the right drug target: emerging methods and strategies

ZC Jia, X Yang, YK Wu, M Li, D Das… - Pharmacological …, 2024 - pharmrev.aspetjournals.org
Drug targets are specific molecules in biological tissues and body fluids that interact with
drugs. Drug target discovery is a key component of drug discovery and is essential for the …

Boosting reactive oxygen species generation with a dual-catalytic nanomedicine for enhanced tumor nanocatalytic therapy

G Su, H Xu, FF Zhou, X Gong, S Tan… - ACS Applied Materials & …, 2023 - ACS Publications
Generating lethal reactive oxygen species (ROS) within tumors by nanocatalytic medicines
is an advanced strategy for tumor-specific therapy in recent years. Nevertheless, the low …

Carrimycin, a first in-class anti-cancer agent, targets selenoprotein H to induce nucleolar oxidative stress and inhibit ribosome biogenesis

LYC Yu, DD Dang, S Zhuang, S Chen… - Cancer pathogenesis …, 2023 - mednexus.org
Carrimycin is a synthetic macrolide antibiotic that has been shown to have anti-cancer
activity; however, its exact mechanism of action and molecular target were previously …

Organic selenocompounds: are they the panacea for human illnesses?

PA Nogara, ME Pereira, CS Oliveira, L Orian… - New Journal of …, 2023 - pubs.rsc.org
The selenium element is essential to some life forms and its biological-chemistry function is
mainly performed by the selenol/selenolate moiety (–SeH/–Se–) in a few selenoproteins …

Effects of selenoprotein extracts from Cardamine hupingshanensis on growth, selenium metabolism, antioxidant capacity, immunity and intestinal health in largemouth …

H Zhang, L Zhao, P Zhang, Y Xie, X Yao… - Frontiers in …, 2024 - frontiersin.org
This study aimed to assess the impact of dietary selenoprotein extracts from Cardamine
hupingshanensis (SePCH) on the growth, hematological parameters, selenium metabolism …

The semisynthesis of nucleolar human selenoprotein H

RN Dardashti, S Laps, JS Gichtin, N Metanis - Chemical Science, 2023 - pubs.rsc.org
The human selenoprotein H is the only selenocysteine-containing protein that is located in
the cell's nucleolus. In vivo studies have suggested that it plays some role in DNA binding …

[HTML][HTML] Isovalerylspiramycin I alleviates liver injury and liver fibrosis by targeting the nucleotide-binding protein 2 (NUBP2)-vascular non-inflammatory molecule-1 …

N Zhang, W Niu, W Niu, Y Li, S Guo, Y Li, W He… - Journal of …, 2024 - Elsevier
Liver fibrosis is a vital cause of morbidity in patients with liver diseases and developing
novel anti-fibrotic drugs is imperative. Isovalerylspiramycin I (ISP I) as a major component of …

[HTML][HTML] Isovalerylspiramycin I suppresses small cell lung cancer proliferation via ATR/CHK1 mediated DNA damage response and PERK/eIF2α/ATF4/CHOP …

Y Xu, X Gu, S Shan, Z Liu, S Wang, J Zhang… - Biochemical …, 2024 - Elsevier
Small cell lung cancer (SCLC) urgently needs new therapeutic approaches. We found that
the antibiotic-derived compound Isovalerylspiramycin I (ISP-I) has potent anti-tumor activity …

A Case of Multidrug-Resistant Klebsiella pneumoniae Treated with Carrimycin

W Zhu, Y Tian, L Xiang, L Cao, L He - Infection and Drug …, 2023 - Taylor & Francis
One of the most pressing emerging issues in bacterial resistance is multidrug-resistant
Klebsiella pneumoniae. The treatment of K. pneumoniae infections is often problematic …

Carrimycin ameliorates lipopolysaccharide and cecal ligation and puncture-induced sepsis in mice

LAI Junzhong, J Liang, C Kunsen, G Biyun… - Chinese Journal of …, 2024 - Elsevier
Carrimycin (CA), sanctioned by China's National Medical Products Administration (NMPA) in
2019 for treating acute bronchitis and sinusitis, has recently been observed to exhibit …